Appointment Reflects Leadership Role Within Southern California’s Life Sciences Community
Los Angeles, CA – 2025 — Avesta Bio announced that CEO and Co-Founder Ian Akash Morrison was named to the BioScienceLA Week Hosting Committee for 2025.
BioScienceLA Week is an annual convening of leaders across biotechnology, healthcare, academia, investment, and public policy in the Greater Los Angeles region. The event serves as a platform to highlight innovation, foster collaboration, and strengthen the life sciences ecosystem in Southern California.
As a member of the Hosting Committee, Mr. Morrison contributed to shaping programming, facilitated strategic engagement among stakeholders, and supported initiatives designed to elevate the region’s biotechnology profile nationally and internationally.
“Southern California continues to emerge as a significant hub for translational medicine and biotechnology innovation,” said Ian Akash Morrison. “It is an honor to serve alongside fellow leaders committed to building a strong, collaborative ecosystem that supports scientific advancement and patient impact.”
Mr. Morrison’s appointment reflects Avesta Bio’s growing presence within the Southern California biotechnology community as the company advances its lead oncology program toward Phase I clinical development. The company remains actively engaged with regional academic institutions, investors, and strategic partners.
About Avesta Bio
Avesta Bio is a translational oncology company developing first-in-class therapies that target fundamental cellular stress-response and drug-resistance pathways. By correcting maladaptive cellular programs implicated in cancer progression, the company aims to deliver safe and effective treatments for patients with high-unmet-need malignancies.
The company is advancing its lead therapeutic program through global partnerships supporting IND-enabling studies, GMP manufacturing, and early-phase clinical development.
For more information, visit: www.avestabio.com